Predictors of Post Operative Outcome in Peripheral Vascular Surgical Patients

Sponsor
York Teaching Hospitals NHS Foundation Trust (Other)
Overall Status
Completed
CT.gov ID
NCT01417910
Collaborator
(none)
100
1
37
2.7

Study Details

Study Description

Brief Summary

Over 3000 people each year undergo bypass operations to their lower limbs, and these operations carry significant risks with approximately 1 in 20 of these people dying in hospital, and another 1 in 20 having a heart attack.

Assessment of these patients in order to stratify their risk of both dying and having significant complications aid in improving their care, enable better utilisation of scarce critical care resources, and allow us to give patients better information on which to base consent.

Aims The aims of the project are to assess the feasibility of exercise testing this group of patients both with cycle and arm exercise, and to identify markers of outcome in this group.

Methodology This is a prospective observational study designed to test the hypothesis that a combination of cardiopulmonary exercise testing and blood tests provides prognostic value on outcome measures after surgery for lower limb revascularisation

Subjects will have 2 exercise tests, one arm and one cycle, prior to surgery at their preoperative assessment appointment. From these tests we will measure how much work patients can do, how much oxygen they are able to use, and when the heart is unable to deliver enough oxygen to the cells. In addition they will have blood samples taken prior to the operation (brain natriuretic peptide), and on days 1 and 3 (troponin I) after the operation to look at cardiac markers of damage.

This data will be used to see if we can predict those patients that have both short and long term complications, and also to see whether the different forms of exercise testing are comparable, or if one type is superior.

Expected outcomes We expect that through a combination of exercise testing and blood test we will be able to identify patients at increased risk of complications after surgery. We also expect to find that arm exercise will be a more feasible and informative test that cycle exercise.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Background Over 3000 people each year undergo bypass operations to their lower limbs, and these operations carry significant risks with approximately 1 in 20 of these people dying in hospital, and another 1 in 20 having a heart attack. The number of people having this type of procedure has grown over recent years and the trend is predicted to continue. Due to this significant increase in the volume of these patients, and the associated complications that occur with this surgery, utilisation of more resources such as critical care is often needed.

    Assessment of these patients in order to stratify their risk of both dying and having significant complications aid in improving their care, allow better utilisation of scarce critical care resources, and also allow us to provide patients with better information as part of the informed consent process.

    A high risk group in major abdominal surgery can be identified through a simple exercise test (cardiopulmonary exercise test) that looks at how the body uses oxygen, and also through a blood test that look at a hormone secreted by the heart. Vascular surgical patients are at risk for the development of major cardiac complications in the postoperative period but a system for appropriate preoperative risk stratifications has yet to be achieved.

    Aims The aims of the project are to assess the feasibility of exercise testing this group of patients both with cycle and arm exercise, and to identify markers of outcome in this group. Identification of markers that can predict how patients will fare after surgery will allow us to improve the informed consent process, utilise resources more effectively and efficiently and identify opportunities to attempt to modify outcomes.

    Methodology This is a prospective observational study designed to test the hypothesis that a combination of cardiopulmonary exercise testing and blood tests provide prognostic value on outcome measures after surgery for lower limb revascularisation.

    Participants will have 2 exercise tests, one arm and one cycle, prior to surgery at their preoperative assessment appointment. From these tests we will measure how much work patients can do, how much oxygen they are able to use, and when the heart is unable to deliver enough oxygen to the cells. In addition they will have blood samples taken prior to the operation (brain natriuretic peptide), and on days 1 and 3 (troponin I) after the operation to look at cardiac markers of damage.

    This data will be used to see if we can predict those patients that have both short and long term complications, and also to see whether the different forms of exercise testing are comparable, or if one type is superior.

    Expected outcomes We expect that through a combination of exercise testing and a blood test we will be able to identify patients at increased risk of complications after surgery. We also expect to find that arm exercise will be a more feasible and informative test that cycle exercise.

    Implications Identification of a high risk group would allow appropriate strategies to be implemented to reduce risk, and allow better post-operative resource utilisation. This study will also allow a larger multicentre study to be adequately powered and constructed.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    100 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Prognostic Markers of Outcome in Patients Undergoing Infra-inguinal Revascularisation. A Prospective Observational Study.
    Study Start Date :
    Sep 1, 2011
    Actual Primary Completion Date :
    Oct 1, 2014
    Actual Study Completion Date :
    Oct 1, 2014

    Arms and Interventions

    Arm Intervention/Treatment
    Peripheral vascular disease

    Subjects who have peripheral vascular disease

    Outcome Measures

    Primary Outcome Measures

    1. 1 year all cause mortality [1 year]

    Secondary Outcome Measures

    1. 1 year major adverse cardiac event. [1 year]

    2. Morbidity as measured by the Post operative morbidity survey [7 days]

    3. major adverse cardiac event. [participants will be followed for the duration of hospital stay, an expected median of 10 days]

    4. 30 day all cause mortality. [30 day]

    5. Surgical post operative complications [participants will be followed for the duration of hospital stay, an expected median of 10 days]

      participants will be followed for the duration of hospital stay, an expected median of 10 days

    6. Medical post operative complications [participants will be followed for the duration of hospital stay, an expected median of 10 days]

      participants will be followed for the duration of hospital stay, an expected median of 10 days

    7. Quality of life measured at 6 and 12 months postoperatively by the EQ-5D-5L questionnaire. [0,6 and 12 months]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 99 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • All patients undergoing elective and expedited infra inguinal peripheral revascularisation. Patients undergoing radiological assessment (angiography) and/or radiological intervention for peripheral vascular disease
    Exclusion Criteria:
    • Patients refusing to participate in the study or unable to give informed consent.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 York Teaching Hospitals NHS Foundation Trust York North Yorkshire United Kingdom YO318HE

    Sponsors and Collaborators

    • York Teaching Hospitals NHS Foundation Trust

    Investigators

    • Principal Investigator: Simon J Davies, MBChB, York Teaching Hospital NHS Foundation Trust

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    York Teaching Hospitals NHS Foundation Trust
    ClinicalTrials.gov Identifier:
    NCT01417910
    Other Study ID Numbers:
    • PVD10
    First Posted:
    Aug 16, 2011
    Last Update Posted:
    Jan 27, 2016
    Last Verified:
    Feb 1, 2015
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 27, 2016